Email this article 
SURGICAL REHABILITATION IN PATIENTS WITH POSTRADIATION VESICOVAGINAL FISTULAS IN CANCER OF THE CERVIX UTERI
- Authors: Semirdzhanyants E.G.1, Petrovsky A.V.1,2, Fanshtein I.A.1, Nechushkin M.I.1, Avtomonov D.E.1
-
Affiliations:
- N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- I. M. Sechenov First Moscow State Medical University
- Issue: Vol 9, No 4 (2013)
- Pages: 66-70
- Section: UROLOGICAL COMPLICATIONS IN CANCER PATIENTS
- Published: 30.12.2013
- URL: https://oncourology.abvpress.ru/oncur/article/view/151
- DOI: https://doi.org/10.17650/1726-9776-2013-9-4-66-70
- ID: 151
Cite item
Full Text
Abstract
Background. Radiotherapy is a basic treatment for patients with locally advanced cancer of the cervix uteri (CCU). However, in 20–30 % of patients, postradiation injuries result from different causes, which may give rise to fistulas.
Objective: to define an optimal surgical rehabilitation method for patients with postradiation vesicovaginal fistulas in CCU.
Subjects and methods. Forty-eight patients with CCU and postradiation vesicovaginal fistulas were operated on in 1996 to 2010. Patients with primary fistulas underwent 46 radical operations and 2 palliative ones; those with recurrent fistulas had 17 radical operations and 1 palliative one.
Results. Recurrences after radical surgery for primary fistulas occurred in 39.1 % of the patients; the efficiency was 80.0 % for transvaginal plasty, 61.5 % for bladder resection, 61.5 % for bladder resection with ureteral reimplantation, and 0 for subtotal bladder resection. In recurrent fistulas, the efficiency was 0 for bladder resection with ureteral reimplantation, 50 % for subtotal bladder resection, and 100 % for cystectomy, Bricker surgery. Surgical rehabilitation could be achieved in a total of 40 (83.3 %) of the 48 women.
Conclusion. The correct choice of surgical scope allows the satisfactory results of treatment for postradiation fistulas to be achieved in patients with CCU.
About the authors
E. G. Semirdzhanyants
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: 3005757@mail.ru
Russian Federation
A. V. Petrovsky
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow;I. M. Sechenov First Moscow State Medical University
Email: 3005757@mail.ru
Russian Federation
I. A. Fanshtein
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: 3005757@mail.ru
Russian Federation
M. I. Nechushkin
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: 3005757@mail.ru
Russian Federation
D. E. Avtomonov
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: 3005757@mail.ru
Russian Federation
References
Supplementary files
